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Abstract 28 
Kisspeptin and attributes in infertile males and females: a cross sectional 29 
study in a subset of Pakistani Population. 30 
Kisspeptin; a peptide hormone, plays a pivotal role in fertility and 31 
neuroendocrine regulation of hypothalamo-pituitary gonadal axis. Increased 32 
kisspeptin and reproductive hormones are responsible for fertility in male and 33 
females. This study aimed to explore the role of kisspeptin on hypothalamo-34 
pituitary-gonadal axis by comparing the levels of kisspeptin in fertile and 35 
infertile subjects and identifying single-nucleotide polymorphisms(SNP) of 36 
KISS1 gene in exon 2 and 3 of infertile male and female cohorts. A cross-37 
sectional study was carried out on 80 males (44 infertile and 36 fertile) and 88 38 
females (44 in each group). Significantly high levels of kisspeptin(KP), follicle 39 
stimulating hormone(FSH), luteinizing hormone and testosterone were observed 40 
in fertile male and female subjects except low FSH levels in comparison to 41 
infertile female subjects. One polymorphism in exon 2 [E1225K (G/A 3673)] 42 
and three in exon 3 [P1945A (C/G 5833); Insertion of T at 6075; G2026G (C/G 43 
6078)] in infertile group were detected; with low KP and hormonal levels. Male 44 
subjects had abnormal sperm parameters and unsuccessful attempt of 45 
Intracytoplasmic sperm injection in females. Expression of SNP in exon 2 and 3 46 
of KISS1 could be responsible for alteration in release of reproductive hormones 47 
and gonadal functions, hence causing infertility.  48 
Key words: Kisspeptin, Infertility, KISS1, polymorphism 49 
1. Introduction:  50 
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Kisspeptin (KP) encoded by KISS1 belongs to a family of peptide hormones 51 
which play a principal role in fertility and neuroendocrine regulation of 52 
hypothalamo-pituitary gonadal axis (Vaziri, Rafeie et al. 2017).  KP secreting 53 
neurons are present in the different nuclei of hypothalamus; arcuate nucleus 54 
(ARC) also known as infundibular nucleus, the anteroventral peri-ventricular 55 
nucleus (AVPV), anterodorsal preoptic nucleus (APN), stria terminalis and 56 
Amygdale (Funes, Hedrick et al. 2003). The pulsatile secretion of Gonadotropin 57 
Releasing Hormone (GnRH) in central regulation of the Hypothalamo-pituitary 58 
gonadal (HPG) axis is played by hypothalamic KISS1/KISS1R (receptor of KISS 59 
1) system (Skorupskaite, George et al. 2014). Consequently, the cross-talk 60 
between Kisspeptin and the receptor (KISS1R) stands crucial in regulating the 61 
commencement of puberty and release of hormones from the involved 62 
reproductive axis (Luan, Zhou et al. 2007)  63 
KISS1 translates for a 145 amino acid long protein identified as kisspeptin-145 64 
which produces a peptide containing 54 residues after cleavage, called 65 
Kisspeptin 54 or metastin that can further be sliced into much smaller amino acid 66 
sequences, recognized as kisspeptin-14, kisspeptin-13 and kisspeptin-10, 67 
however they represent a common structural motif (ArgPhe-NH2) in their C-68 
terminal (de Tassigny, Fagg et al. 2007). Along the length of gene KISS1, more 69 
than approximately 294 single nucleotide polymorphism (SNPs) are already 70 
identified; among which the untranslated region (UTR) contributes to have 42 71 
mutations, exon for 30 and the rest by intronic regions. [“A database of human 72 
single nucleotide polymorphisms” 2014, http://www.ncbi.nlm.nih.gov/SNP/].  73 
 KISS1R gene mutations result in loss of function of the KISS1R, leading to 74 
down-regulation of GnRH pulsatile secretion as well as infertility. On the other 75 
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hand, activating mutations cause prevention of desensitization of the 76 
KISS/KISS1R pathway and ultimately lead to precocious puberty. Two KISS1 77 
mutations, p.P74S and p.H90D, have been recognized as genetic causes of 78 
Central Precocious Puberty (Silveira, Noel et al. 2010). Furthermore, 79 
polymorphism of the KISS1 gene with amino acid substitution (P110T) 80 
documented to have significant association with central precocious puberty 81 
(CPP) in Korean girls (Luan, Zhou et al. 2007) (Ko, Lee et al. 2010)  82 
 The role of KP in feedback regulation of GnRH secretion and hence release of 83 
gonadal hormones required for normal reproductive functions has been 84 
elucidated (Irwig, Fraley et al. 2004). Evidence advocates the loss of gene 85 
functionality or presence of SNPs in KISS1 and KISS1R to be a risk factor for 86 
sexual immaturity and infertility axis in humans (Ko, Lee et al. 2010).  87 
A number of studies have verified role of Kisspeptin on reproductive axis, 88 
unexplained infertility and as a therapeutic agent to trigger oocyte maturation 89 
and ovulation (Abbara, Jayasena et al. 2014), (Mumtaz, Khalid et al. 2017). 90 
Literature has proved that mutations which inhibit the action of KISS1 and 91 
KISS1R in idiopathic hypo-gonadotropic-hypogonadism (IHH) subjects resulted 92 
in delayed puberty and subfertility (Semple, Achermann et al. 2005) .  93 
Although mutations inhibiting KISS1 gene and its receptor activity can instigate 94 
infertility yet, the information about KISS1 gene mutations and its 95 
polymorphisms are scarce. A research done on Q36R (rs35431622) KISS1 gene 96 
in infertile female subjects in northern Iran documented that it has no association 97 
with female infertility and suggested  that variation of results might be possible  98 
due to  genetic variations on account of different geographic situations (Vaziri, 99 
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Rafeie et al. 2017). In addition to that, low levels of KP have also been identified 100 
in infertile male subjects of our region (Haris Ramzan, Ramzan et al. 2015).  101 
We thus aimed to explore role of KP on HPG axis by comparing KP levels in 102 
fertile and infertile male and female subjects and identify the sequence 103 
variations, including mutations and single-nucleotide polymorphisms (SNPs) of 104 
KISS1 gene in exon 2 and 3 of infertile males and female cohorts. 105 
Subjects and Methods:  106 
This cross-sectional study was conducted in the Department of Biological & 107 
Biomedical Sciences, Aga Khan University, Karachi, from April 2016 till March 108 
2018 after acquiring ethical approval (3331-BBS-ERC-14).  The estimated sample 109 
size by observing 94% power, with prevalence of 21.9% infertility and 22%+/-6 110 
confidence limit, was 79. To avoid drop out of subjects we recruited 88 infertile 111 
(male and female) subjects and matched 80 fertile subjects, who fulfilled our 112 
inclusion criteria and consented to be part of our study.  113 
Phenotypic Characterization: 114 
Inclusion Criteria for Male Subjects; 115 
All males between the ages of 25 to 55 years during the study phase who 116 
concurred to take part in the study were selected. A comprehensive history 117 
related to the diagnosis of infertility was obtained for excluding secondarily 118 
infertile males. A semen analysis report was obtained on request (6 to 9 months 119 
old). In case of failure to do so, male subjects were demanded a fresh semen 120 
samples by masturbation following a 3 - 5 days of asceticism. Samples were then 121 
processed and stored in sterilized containers, later were analyzed as per World 122 
Health Organization guidelines.  123 
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Fertile Group:  124 
The “fertility status” of the recruited subjects was established according to the 125 
semen parameters observing the World Health Organization criteria “2010” 126 
which states “had total sperm number (TC) >39 million per ejaculate, total sperm 127 
motility (Progressive and Non-progressive) measured within 60 minutes of 128 
collection of more than 40%, and normal morphology of  4%.” (Cooper, 129 
Noonan et al.)  130 
Infertile group: 131 
Men with history of primary infertility; sperm number (TC) less than 39 132 
million/ejaculate, decreased sperm motility of all sperms (less than 40%) and 133 
having normal sperm morphology of less than 4% (Cooper, Noonan et al. 2010) 134 
were included in the study. 135 
Exclusion Criteria for Male Subjects:  136 
Subjects having diabetes, hypertension, arthritis, malignancy, epilepsy, 137 
tuberculosis, endocrinal disorders, liver/renal disease, cryptorchidism, testicular 138 
trauma, orchitis, testicular hypotrophy along with those who had general health 139 
issues were excluded. Additionally, those who suffered from secondary 140 
infertility were discounted. Moreover, subjects who were receiving any 141 
hormonal or steroids therapy were also excluded. 142 
Inclusion Criteria for Female Subjects:  143 
Fertile females:  144 
All healthy females between the ages of 18 - 35 years, with a child less than 2 145 
years of age from all ethnic groups were recruited as controls. 146 
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Infertile females:  147 
All females who fulfill the criteria of primary infertility (never conceived in last 148 
more than one years) between the ages of 18 - 35 years, from all ethnic 149 
backgrounds, were enrolled in the study as cases. 150 
 151 
Exclusion criteria for Female subjects:  152 
The females who were diagnosed with secondary infertility, being treated with 153 
oral contraceptive pills, having thyroid disorders, preexisting diabetes and 154 
hypertension were excluded from the study.  155 
Clinical Data Collection: The clinical data including age, height, weight, blood 156 
pressure, menstrual/obstetric and gynecological history with general physical 157 
examination was recorded in all study subjects. The height in centimeters 158 
(converted to meters) and weight in kilograms of all the recruited subjects were 159 
noted to calculate the body mass index (BMI), and categorized consulting 160 
cutoffs for Asians, where 18 - 22.9 kg/m² was normal weight, overweight 23 - 161 
24.9 kg/m² was overweight and BMI ≥ 25 kg/m² was considered obese (WHO 162 
2004). Gender, age and height of every participant was entered manually into 163 
the BIA machine by a digital keyboard, and it immediately revealed the 164 
percentage fat mass (% FM) of the individual (Lazzer, Boirie et al. 2003) 165 
Biochemical Measurement 166 
Serum samples were used to detect the hormones levels using commercially 167 
available Enzyme Linked Immuno Sorbent Assay (ELISA) kits, following the 168 
manufacturer’s protocol. Follicle stimulating hormone (FSH) by Human FSH 169 
Enzyme Immunoassay (Kit Cat. No DKO010; DiaMetra), LH by Human LH 170 
Enzyme Immunoassay (Kit Cat. No DKO010; Dia Metra). Immunoassay for 171 
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FSH, the inter assay coefficient of variation, <8% and intra assay coefficient of 172 
variation, <9.7% and similarly LH immunoassay, the inter assay coefficient of 173 
variation was <7.91%; intra assay coefficient of variation was <9.21%. Serum 174 
KP was measured by ELISA kit (Cat. No: 95611, Glory BioScience, USA). The 175 
analytical sensitivity was 10.16 ng/L and intra and inter assay coefficients of 176 
variation was less than 10% and 12%, respectively. For assessing total 177 
testosterone levels commercially available Human Total Testosterone (TT) 178 
immune-enzymatic kit for serum analysis was utilized (Cat. No DKO002 by 179 
Diametra). 180 
Genotype Characterization: 181 
Blood Sampling and genotyping: 182 
  Ten ml of venous blood was collected form all study subjects. DNA was isolated 183 
from the leukocytes in the peripheral blood of the study subjects using a DNA 184 
isolation kit (Genomic DNA Purification Kit Cat. No A1125 by Promega, USA). 185 
The isolated DNA was quantified by measuring the ultraviolet (UV) absorbance 186 
and determining the absorbance ratio (A280/A260) for 2 μ L samples, employing a 187 
Nanodrop-ND1000 (Thermo Fisher Scientific, Waltham, MA). Extracted DNA was 188 
considered pure at an absorbance ratio of ~1.8. Furthermore, gel electrophoresis 189 
was run to visualize the PCR products on 5μL of sample in 2% agarose gel against 190 
a 100bp ladder on approximately 15% of all samples for confirmation. Gel was 191 
observed in Gel Doc Imaging system (Biorad, United Kingdom) (Figure 1a & b). 192 
For exon 2: Polymerase chain reaction (PCR) was executed using the 2X PCR 193 
Hotstart Master Mix (Cat# G906, ABM (Applied Biological Materials Inc, Canada) 194 
according to the instructions mentioned on the provided manual. The cycle 195 
conditions during PCR were: 1 cycle for 5 min at 95 °C for initial denaturation 196 
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followed by 40 cycles at 95 °C for 20 seconds, 65°C for 15 seconds s, 72 °C for 15 197 
seconds, followed by a final extension of 1 min at 72 °C.  198 
For exon 3: PCR was executed employing the Go Taq (R) Hotstart Green Master 199 
mix (Cat #M5122, Promega Corporation, USA) according to the instructions 200 
mentioned on the provided manual. The cycle conditions during PCR were: 1 cycle 201 
for 5 min at 95 °C for initial denaturation followed by 35 cycles at 95 °C for 30 s, 202 
58°C for 45 s, 72 °C for 45 s followed by a final extension of 10 min at 72 °C.  203 
Purification of the PCR products was done using PCR Clean Up for DNA 204 
Sequencing (Cat. No BT5100, Bio Basic Inc, Canada) following the manufacturer 205 
protocol. Genotypic analysis was performed to detect mutations responsible for 206 
infertility by PCR amplification of the fertile and infertile male (n=80) and female 207 
subjects (n=88) within the region of exon 2 (214bp) and exon 3 (606bp) of KISS1 208 
gene. The obtained sequences were directly compared to previously published 209 
KISS1 gene sequence using the MEGABLAST search tool in the National Center 210 
for Biotechnology Information (NCBI) database. Sequence files were imported into 211 
Chromas Lite, and then assembled using Molecular Evolutionary Genetic Analysis 212 
version 6.0. 213 
All coding exons (exons 2 and 3) of KISS1 gene were PCR amplified with specific 214 
primers as follows: 215 
 216 





Statistical Analysis: Statistical analyses were performed using IBM Statistical 217 
Package for the Social Sciences (IBM SPSS version 21; IBM Corp Inc, Armonk, 218 
NY). Continuous variables (such as age, LH, FSH etc.) were represented as Mean 219 
± standard deviation and the evaluation of the categorical variables (BMI) was 220 
expressed in terms of frequencies and percentages. To compare continuous and 221 
categorical variables, Independent sample t-test and Pearson’s chi square test was 222 
applied. Correlations were adjusted for age and BMI for hormonal associations 223 
(logistic regression). SNP data was calculated by chi-squared statistics, Odds ratio 224 
with 95% confidence interval was calculated for genotype and allele frequency 225 
analysis.  226 
Results: 227 
The results of the study showed that infertile males were obese and were at a 228 
lower age bracket as compared to fertile group (p<0.001). Furthermore, the 229 
infertile females also demonstrated a higher BMI as compared to the fertile 230 
females (p<0.001). The sperm count and motility was decreased along with 231 
increased abnormal morphology in the infertile males as compared to the fertile 232 
males (p<0.01)  (Table 1). A similar trend in terms of hormonal profile was 233 
observed in the infertile female subjects; however, no difference for age was 234 
recorded (Table 1). Comparison of hormones in Table 2 show significantly high 235 
levels of KP, FSH, LH and Testosterone in fertile male, however KP, LH and 236 
Estradiol levels were significantly higher in fertile female subjects with low FSH 237 
levels. When tested for the correlations of Kisspeptin levels on the male 238 






moderate positive relationship with KP levels (r=0.67; p=<0.001), while 240 
Testosterone (r=0.38; p=<0.01) showed weak correlation with fertility in all 241 
subjects. Similarly, KP showed weak positive correlation with Estradiol 242 
(r=0.466; p=0.001) while no relationship was observed with LH and FSH. All 243 
correlations were lost when adjusted for age and BMI (p>0.05).  244 
Table 3 shows the genotype distribution of the polymorphic EXON 2 and 3 245 
sequences. This study was able to identify one polymorphism in exon2 [E1225K 246 
(G/A 3673)] and 3 unique polymorphisms in exon3 [P1945A (C/G 5833); 247 
Insertion of T at 6075; G2026G (C/G 6078)] in the study population. 248 
Interestingly, these polymorphisms were observed in higher frequency in 249 
infertile group (both genders) versus the fertile; yet the presence or absence of 250 
polymorphic site in both exons of interest failed to reveal any significant 251 
difference in this study population (p>0.05).  252 
This study documented one novel result in the study cohort. In a sample of n=80 253 
males and n= 88 females; 03 subjects in each sex group tested positive for all 03 254 
of the polymorphisms in exon-3 region. When their data was linked with the 255 
polymorphic status; it was observed that 04 out of 06 individuals (male female 256 
combined) were smokers with low KP and its related hormonal levels at various 257 
points during the study. Furthermore, their sperm parameters fell in the abnormal 258 
category (males) or attempt at Intracytoplasmic Sperm injection (ICSI) was 259 
unsuccessful (females) (Table 4 and 5).  This result shows a probable effect of 260 
environmental changes on genetic alterations in the KP gene and its secondary 261 
effect on the reproductive axis.  262 
Discussion: 263 
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The relationship of KP with the interruption of hypothalamic-pituitary-gonadal 264 
axis can be demonstrated by high concordance of the phenotypes between 265 
comparable genetic variants present in GnRH receptor, FSH and its receptor, LH 266 
and its receptor in mice and humans (Rehman, Jamil et al. 2015). In male 267 
subjects, we have observed low levels of KP with concomitant decrease in 268 
gonadotropin and sex steroid hormone levels, which is comparable to studies in 269 
male infertile subjects(Haris Ramzan, Ramzan et al. 2015). This can probably 270 
be an explanation of KP role in preservation of spermatogenesis and hence 271 
fertility. Low FSH levels was observed in normozoospermic and azospermic  272 
infertile male subjects  by Ramzan et al which was not significantly different in 273 
fertile and infertile males (Haris Ramzan, Ramzan et al. 2015). The significant 274 
low FSH levels in infertile male subjects of our study may be explained by lack 275 
of stratification of subjects into infertile categories on the basis of sperm 276 
parameters. In the female infertile subjects a high FSH explains the negative 277 
feedback interplay on HPG axis due to decrease in Estradiol secretion. Literature 278 
also supports a raised FSH in infertile females (Prasad, Parmar et al. 2015).   279 
Kisspeptin is now safely and successfully used in both healthy and infertile 280 
human subjects after trials in United Kingdom, and it is possible that in the future 281 
the Kisspeptin signaling may be used as a target in the treatment of reproductive 282 
disorders (Hameed, Jayasena et al. 2011). 283 
The role of Kisspeptin injections to stimulate the secretion of LH and FSH in 284 
numerous mammalian species including rats, mice, sheep, cows and monkeys is 285 
supportive of our statement (Navarro, Castellano et al. 2005). Furthermore, a 286 
study done by Dhillo et al 2015, documents that KP infusion significantly 287 
increased plasma LH, FSH, and testosterone levels (Clarke, Dhillo et al. 2015) 288 
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is supportive of our study in which infertile  study subjects had low KP, LH, 289 
FSH and testosterone in male subjects. The correlation of KP with estradiol in 290 
both genders explains that KP requires estradiol secretion to stimulate GnRH 291 
secretion as suggested by the study in which ovariectomy abolished the KP-292 
induced GnRH release in pubertal monkeys, and estradiol replacement resulted 293 
in partial recovery of KP- induced GnRH release (Guerriero, Keen et al. 2012). 294 
Kisspeptin represents and should be investigated in the treatment of fertility 295 
disorders characterized by low gonadotropins or anovulation. (Clarke, Dhillo et 296 
al. 2015)  297 
Higher KP in non-obese males and non-obese young females were observed in 298 
our study, which might be due to the fact that KP effects negatively on body 299 
weight and calorie consumption (Walewski, Ge et al. 2014, Stengel 2011 #214, 300 
(Lin, 2015 #216). BMI and body fat % age were noted to be high in infertile 301 
groups while KP was low which is perhaps due to certain changes in the sex 302 
hormones which regulates obesity by increasing the serum triglycerides levels 303 
(Shamai, Lurix et al. 2011, Kołodziejski, Pruszyńska-Oszmałek et al. 2018). It 304 
is a well-established fact that there are various mechanisms how obesity causes 305 
infertility (Talmor and Dunphy 2015).There is an ample evidence that KP 306 
signaling tends to decrease the metabolic rate and initiates glucose intolerance 307 
and increased body fat (Holmes 2014).  308 
In this study, no clear-cut difference was observed in the genetic mutations 309 
amongst fertile and infertile males and female subjects.  Three unique KISS1 310 
mutations were identified all together in unrelated subject in each gender 311 
category. The absence of this variant in the fertile female group suggests that 312 
this is a rare mutation which has a major qualitative effect on the KISS gene. 313 
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However only 1 fertile male tested positive for this mutation; when we checked 314 
the paternal age and status of fertility in the last 5 years, it was identified that 315 
this gentleman was 33-year-old and had a baby 4 years ago. Perhaps this 316 
substitution mutation is related to the age group and environmental or stress 317 
related changes. There are examples in literature where same SNPs resulted in 318 
diverse expressions. As an example in Chinese population a SNP of amino acid 319 
substitution (P110T) in KISS1 in females with CPP was found to be statistically 320 
interconnected to infertility whereas in Korean girls the same mutation had a 321 
protective effect on infertility (Luan, Zhou et al. 2007) (Ko, Lee et al. 2010). 322 
Yet, no data is available from the current literature to support this claim. 323 
Therefore, more work is required to assess the functionally or causality of this 324 
mutation with infertility.   325 
In terms of mutations in exon 3, we found no link of the SNP’s with infertility. 326 
These mutations i.e. insertion of Thiamine at position 6075 and substitution of 327 
Proline to Alanine at position 1945 may be explained as due to faulty gene 328 
regulation process related with age, since all these individuals were in the age range 329 
of 34 to 48 year. Interestingly, in the fertile group with these mutations; one female 330 
had delivered a baby within last 7 months. This finding suggests that silent 331 
mutations at these positions, does not affect the functional role of Kisspeptin 332 
protein. The study is limited in terms of being a uni-centric study with a small 333 
sample size in which the impact of polymorphism in infertile females on the basis 334 
of cause of infertility has not been taken into consideration. Furthermore, the 335 
association of gene variation of KISS1 could have been further validated in terms 336 
of impact on different altered sperm parameters.   337 
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However, this is the first study in this region that has attempted to explore a cause 338 
effect relationship of Kiss1 gene variation with hormones of reproduction and 339 
impact on fertility status in both male and female infertile subjects.  340 
Conclusion: Role of KP in regulation of normal reproductive functions can be 341 
explained on the basis of its effect on secretion of gonadotropins and sex steroids. 342 
Polymorphism in exon2 [E1225K (G/A 3673)] and 3 unique polymorphisms in 343 
exon3 [P1945A (C/G 5833); Insertion of T at 6075; G2026G (C/G 6078)] can be 344 
further explored as plausible cause of decreased KP production in infertile male and 345 
female subjects. Further detailed studies are warranted for understanding of the 346 
mechanistic role of genetic variations of KP in infertility. 347 
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